US jury reached a USD 382mln verdict against Medtronic (MDT) in an antitrust lawsuit

The USD 382 million verdict against Medtronic in an antitrust lawsuit highlights significant regulatory scrutiny in the health care sector.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

PRE-MARKET AUSTRALIAN STOCKS NEWS: Rio Tinto (RIO AT) and Glencore (GLEN LN) decided against pursuing a mega-merger as Rio Tinto could not reach an agreement delivering shareholder value

RBA Governor Bullock says much of the recent increase in inflation is judged to be temporary, but some of it seems to be persistent, adds Board will be monitoring closely the extent to which the strong inflation we have observed is persistent or temporary

US jury reached a USD 382mln verdict against Medtronic (MDT) in an antitrust lawsuit

Newsquawk Daily Asia-Pac Opening News - 6th February 2026

Japan ruling parties expected to win over 300 seats out of the 465 seats in the lower house election, according to Nikkei

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This outcome could set precedents for future antitrust cases, potentially impacting Medtronic's operational costs and stock performance, while also signaling to investors that regulatory risks are a growing concern in health-related equities.

Related headlines

The whole workspace, free to try.

Try it free